ME/CFS Research Foundation Logo

Extracellular Vesicles from Plasma as Potential Biomarkers for an Improved Diagnosis of Endothelial Dysfunction in ME/CFS

About

Status:
Completed
Principal investigator:
Country:
Germany
Study start:
Not available
Completion (planned):
Not available
Last update:
2023-11-30

 

Research types:
Basic research
Research areas:
Cardiovascular dysfunction
Interventions:
Not applicable
Priv. Sector Partner:
Not available
Sponsors:

Project description

Despite intensive research, the pathomechanism of ME/CFS is currently still not fully understood. It has already been proven that in some patients a disruption of blood vessel regulation and endothelial cell function occurs. Initial preliminary work indicates a change in the quality of plasma factors in ME/CFS patients, such as small RNA molecules and also extracellular vesicles, in associations with blood vessel function. Vesicles from the plasma of ME/CFS patients have already been isolated and differences in their properties were detected compared to vesicles from the plasma of healthy control subjects.

Against this backdrop the aim of this study is to improve the diagnosis of ME/CFS, and to provide insights into the pathogenesis of vascular functioning disorder in patients with ME/CFS. In this project, vesicles from the plasma of post-infectious ME/CFS patients and healthy volunteers will hence be isolated and their properties compared. Vesicle isolation from the plasma of 20 post-infectious ME/CFS patients and 10 healthy control provide the basis for the analysis of molecular vesicle markers and the functional testing of the isolated plasma vesicles in endothelial cells through vessel formation and wound healing assays.

(Description adapted from project website: see link above)

Patient cohort

Post-infectious ME/CFS compared with healthy controls. All female.

Patients enrolled: 30

Age group: Not available

Research areas (2)
Research types (1)
Research networks (0)
Working groups (2)
People (3)
Publications (0)
Organisations (1)